Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil in Paediatric Liver Resection or Transplantation
NCT00365248Phase 3Completed
- Sponsor
- Nycomed
- Start
- Oct 2005
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tachosil in hemorrhage, sponsored by Nycomed. Primary endpoints: Intra-operative haemostatic efficacy and Safety of TachoSil at 7.5 months. Started Oct 2005; status: completed.
02
Drugs
tachosil
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT00365248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365248.